YR

Yugandhar Rao Karmindla

Active Director Director DIN 10746560
DIN 10746560 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Yugandhar Rao Karmindla

Data last updated:

Yugandhar Rao Karmindla is a Director at Olive Drugs Private Limited (since 2024). The company operates in Pharma. Olive Drugs Private Limited reported revenue of ₹14,100 (FY 2024).

DIN 10746560
Primary Designation Director
Industry Pharma
First Appointment 19 Aug 2024
Oldest Company Age 5 yrs
Largest company Olive Drugs Private Limited · ₹14,100 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Olive Drugs Private Limited U24100TG2021PTC153053
Director19 Aug 20242021₹14,100 (FY 2024)Active

Board colleagues of Yugandhar Rao Karmindla

NameDINCompanyDesignation
Sruthiram Mundrathi10746544Olive Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Olive Drugs Private Limited
Premium access

Shareholding and investment profile for Yugandhar Rao Karmindla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yugandhar Rao Karmindla

Yugandhar Rao Karmindla currently holds 1 directorship: Olive Drugs Private Limited (Director, since 19 Aug 2024, revenue ₹14,100 (FY 2024)).

Yugandhar Rao Karmindla was first appointed on 19 Aug 2024 as Director at Olive Drugs Private Limited.

The current boards of Yugandhar Rao Karmindla's companies include Sruthiram Mundrathi (Olive Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available